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Post-translational protein modifications are systems designed to expand restricted genomic 
information through functional conversion of target molecules. ubiquitin-like post-translational 
modifiers  regulate  numerous  cellular  events  through  their  covalent  linkages  to  target 
protein(s) by an enzymatic cascade analogous to ubiquitylation consisting of E1 (activating), 
E2 (conjugating) and E3 (ligating) enzymes. In this study, we report the essential role of uba5, 
a specific activating enzyme for the ubiquitin-like modifier, ufm1, in erythroid development. 
mice lacking uba5 exhibited severe anaemia, followed by death in utero. Although uba5 was 
dispensable for the production of erythropoietin, its genetic loss led to impaired development 
of megakaryocyte and erythroid progenitors from common myeloid progenitors. Intriguingly, 
transgenic expression of Uba5 in the erythroid lineage rescued the Uba5-deficient embryos 
from anaemia and prolonged their survival, demonstrating the importance of uba5 in cell-
autonomous erythroid differentiation. our results suggest that one of the ubiquitin-like protein 
modification systems, the ufm1 system, is involved in the regulation of haematopoiesis. 
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E
merging evidence during the past decade has highlighted the 
importance of ubiquitin and ubiquitin-like proteins (UBLs), 
which conjugate with target molecules through an elaborate 
enzymatic reaction consisting of E1, E2 and E3 (refs 1–4). In the 
initial step, ubiquitin is activated by a ubiquitin-activating enzyme, 
E1, which forms a high-energy thioester bond with ubiquitin by 
means of adenylation in an ATP-dependent manner. In the second 
step, the E1-activated ubiquitin is transferred to a ubiquitin-con-
jugating enzyme, E2, using a thioester linkage. In some cases, an 
E2 can directly transfer the ubiquitin to substrate proteins through 
an isopeptide linkage; however, E2s mostly require the participation 
of a ubiquitin-ligating enzyme, E3, to achieve a substrate-specific 
ubiquitylation reaction in the cells. Although the covalent modifi-
cation of cellular proteins with ubiquitin mainly mediates selective 
protein turnover, modification of intracellular proteins by the UBLs 
regulates  protein  localization,  protein–protein  or  protein–DNA 
interactions and/or biochemical activities. Therefore, these modi-
fications serve various physiological events, including cell survival, 
differentiation and death3,4.
Haematopoiesis is a complex process orchestrated by specific 
transcription factors and cytokines that support the self-renewal, 
differentiation and survival of haematopoietic progenitors at differ-
ent stages of maturation, and defects in these processes often lead   
to pathological conditions such as leukaemia and myelodysplastic   
syndrome5,6. Among UBLs, SUMO regulates erythroid differentia-
tion through sumoylation of GATA1, which is crucial for the control 
of production of erythrocytes, platelets, mast cells and eosinophils7,8. 
Two other UBLs, Atg8 and Atg12, which are essential for autophagy, 
also contribute to mitochondrial elimination by autophagy in devel-
oping erythrocytes9–11. Apart from SUMO and autophagy-related 
UBLs, however, little is known about the biological significance of 
other UBLs in the complex process of haematopoiesis.
Ubiquitin-fold modifier 1 (Ufm1) is a recently identified protein 
modifier12. Ufm1 is synthesized in a precursor form and cleaved 
at  the  carboxy  terminus  by  specific  proteases  such  as  UfSPs13. 
Thereafter, an E1-like enzyme, Uba5, activates the mature Ufm1, 
forming a high-energy thioester bond. The activated Ufm1 is then 
transferred to an E2-like enzyme, Ufc1, through a similar thioester 
linkage12. Finally, Ufm1 is covalently conjugated with functionally 
as-yet-unknown cellular proteins via Ufl1 (E3-ligating enzyme)14. 
The conjugates are cleaved by UfSPs, implying the reversibility of 
the Ufm1-conjugating system (‘ufmylation’)13,14. Because all mol-
ecules (that is, Ufm1, Uba5, Ufc1, Ufl1 and UfSPs) involved in 
ufmylation are conserved in metazoa and plants, but not in yeast, 
the potential roles in various multicellular organisms are of special 
interest. However, the physiological functions of the Ufm1 system 
are completely unknown.
In this study, we provided evidence that Uba5 is a specific acti-
vating enzyme for a ubiquitin-like modifier, Ufm1, and generated a 
Uba5-deficient mouse model. Remarkably, these mice died in utero 
because of severe anaemia associated with defective differentiation 
of both megakaryocytes and erythrocytes. These defects were res-
cued by Uba5 expression in the erythroid and megakaryocytic pro-
genitors, implying cell-autonomous impairment of erythropoiesis 
in Uba5 − / −  mice. Our results suggest that the Ufm1 system has an 
essential role in erythroid differentiation.
Results
Uba5 is a specific activating enzyme for Ufm1. Eight activating 
enzymes for ubiquitylation and UBL modification can be identified 
in  the  human  genome  by  computer-assisted  homology  analysis 
(Supplementary Table S1) (ref. 4). Although most activating enzymes 
activate single targets among the UBLs, some E1-like enzymes can 
activate two distinct UBLs15–17. It was recently reported that Uba5 also 
activates SUMO2, in contrast to the original claim that addressed 
the specificity for Ufm1 (ref. 18). Thus, we first attempted to clarify 
this problematic issue. To determine whether Uba5 can activate 
proteins other than Ufm1, we used an Uba5-mutant in which the 
active site, cysteine (Cys250), was substituted with serine (termed 
Uba5C250S). When the active-site cysteine residue within E1 and E1- 
like enzymes is replaced with serine, an O-ester bond is formed 
instead of a thioester bond with its respective modifier proteins, and 
the intermediates become stable even under reducing conditions12. 
We expressed a FLAG-tagged Uba5C250S (FLAG-Uba5C250S) together 
with each green fluorescent protein (GFP)-tagged UBL in HEK293T 
cells, and then the cell lysate was immunoprecipitated with anti-
FLAG antibody, followed by immunoblot analysis. An intermediate 
between FLAG-Uba5C250S and GFP-Ufm1, but not other GFP-UBLs, 
was clearly recognized (Supplementary Fig. S1a). Moreover, loss of 
Uba5 had no apparent effect on UBL conjugations except for Ufm1 
conjugation (Supplementary Fig. S1b). These results suggest that 
Uba5 is a specific E1 enzyme for Ufm1.
Generation of Uba5 knockout mice. To investigate the in vivo 
functions of the Ufm1 system in mammals, we generated the Uba5 
knockout mouse line. The mouse Uba5 gene is encoded by 12 exons 
that span a 15-kb genomic DNA sequence. The active-site cysteine 
residue, which is essential for the activation of Ufm1, is encoded by 
exon 7. Thus, the targeting vector was designed to substitute this 
exon with a neomycin resistance gene cassette (Supplementary Fig. 
S2a). Disruption of Uba5 was confirmed by the absence of both 
Uba5 transcript and protein in Uba5-homozygous-null (Uba5 − / − ) 
mouse embryonic fibroblasts (MEFs; Supplementary Fig. S2b,c). 
We also tested the loss of Uba5 activity by examining Ufm1 con-
jugation  in  MEFs  and  confirmed  the  loss  of  Ufm1  conjugates 
with some cellular targets (for example, 39- and 51-kDa proteins;   
Supplementary Fig. S2c).
Loss of Uba5 leads to death in utero due to severe anaemia. All 
Uba5 − / −   mice  from  Uba5 + / −   intercrosses  died  in  utero,  whereas 
Uba5-heterozygous  (Uba5 + / − )  mice  were  born  healthy  and  fer-
tile  without  any  noticeable  pathological  phenotype  for  at  least 
2 years. These results indicate that the complete loss of Uba5 is 
embryonically  lethal.  Analysis  of  Uba5 − / −   embryos  at  different 
developmental stages showed that the majority of embryos died 
between 12.5 and 13.5 embryonic days (E) after gestation (Table 1).   
The Uba5 − / −  embryos appeared paler and smaller than their wild-
type littermates (Fig. 1a). The most obvious phenotype was severe 
fetal anaemia.
In mouse embryos, primitive erythropoiesis, which is character-
ized by the production of nucleated erythrocytes, is initiated in the 
yolk sac blood island at E7.0. On the other hand, definitive erythro-
poiesis starts around E11.5 in fetal livers, in which massive amounts 
of enucleated erythrocytes are produced from erythroblasts19. Hae-
matopoietic stem cells in fetal livers continuously replenish eryth-
roid  progenitors  for  the  production  of  erythrocytes  to  support   
embryos  during  late  gestation19.  At  E11.5,  the  total  number  of 
nucleated  erythrocytes  in  Uba5-deficient  liver  was  markedly 
Table 1 | Genotype analysis of Uba5 heterozygous intercross 
progeny.
DNA source Genotype
Uba5 + / +  Uba5 + /– Uba5–/–
Alive Dead
Amnion (E10.5) 11 20 6 0
Amnion (E11.5) 71 168 58 0
Amnion (E12.5) 6 14 4 2
Amnion (E13.5) 4 6 0 3
Tails (4-week-old) 15 36 0 —
Embryos were genotyped by PCR analysis.ARTICLE     
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lower than in the corresponding tissue of wild-type mice (Fig. 1b   
and  c).  Occasionally,  we  observed  multinucleated  erythrocytes 
in the mutant fetal livers (Fig. 1b). These abnormal erythrocytes 
comprised  ε-globin-positive  primitive  and  β-globin-positive 
definitive erythrocytes (Fig. 1d), implicating impairment of both   
primitive and definitive erythropoiesis in Uba5-knockout embryos. 
Indeed, we noticed reduced circulating erythrocytes in the yolk sac 
(Fig. 1e) and abnormal multinucleated erythrocytes in peripheral 
blood (Fig. 1f,g).
Uba5  is  essential  for  the  development  of  erythroid  lineage. 
Haematopoietic progenitor cells can be accurately classified on the 
basis of their developmental potential, as schematically represented 
in  Supplementary  Figure  S3a.  Each  type  of  erythroblast  can  be   
distinguished  by  examining  the  expression  profiles  of  certain   
surface proteins such as CD71 and Ter119 (ref. 20; Supplementary 
Fig. S3b). At E11.5, although Ter119medCD71high proerythroblasts 
and Ter119highCD71high basophilic erythroblasts were present in wild-
type fetal livers, the numbers of both types of cells were diminished 
in Uba5 − / −  fetal livers (10.0 ± 1.2% versus 4.2 ± 3.2% and 23.6 ± 1.6% 
versus  1.0 ± 0.6%,  respectively,  n = 3,  P < 0.05,  Fig.  2a).  Next,  we 
compared  erythroid  colony-forming  units  (CFU-Es)  and  more 
immature erythroid burst-forming units (BFU-Es) in wild-type and 
Uba5 − / −  fetal livers at E11.5. Both types of colonies were formed 
even  in  the  absence  of  Uba5.  However,  the  number  of  Uba5 − / −  
CFU-Es (Fig. 2b) and BFU-Es (Fig. 2c) was significantly lower than 
in wild-type CFU-Es and BFU-Es (58.9% and 33.0%, respectively, 
P < 0.05),  suggesting  reduced  numbers  of  erythroid  progenitors. 
Furthermore, the colony formation assay for megakaryocyte (CFU-
Megs) indicated that cells derived from Uba5-knockout fetal livers 
had a reduced ability to form colonies (see Fig. 4d). These results 
indicate that loss of Uba5 is associated with defective differentiation 
of both megakaryocytes aned erythrocytes.
Each type of common myeloid progenitors (CMPs), granulocyte/
macrophage  progenitors  (GMPs)  and  megakaryocyte/erythroid   
progenitors  (MEPs)  in  the  bone  marrow  of  adult  mice  can  be   
distinguished on the basis of the expression of surface markers21  
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Figure 1 | Loss of Uba5 leads to death in utero because of severe anaemia. 
(a) morphological examination of Uba5 − / −  mice embryos. Representative 
photographs of Uba5 + / +  and Uba5 − / −  embryos at various developmental 
stages. Uba5 − / −  embryo at E12.5 exhibited severe anaemia. scale bar, 2 mm. 
(b) Haematoxylin and eosin staining of fetal liver sections of Uba5 + / +  and 
Uba5 − / −  mice at E11.5. scale bars: left panel, 1 mm; right panel, 20 µm. (c) 
number of erythrocytes in fetal livers of Uba5 + / +  and Uba5 − / −  mice at E11.5. 
(d) Immunohistochemistry of fetal liver sections of Uba5 + / +  and Uba5 − / −  
embryos at E11.5 with anti-ε-globin and anti-β-globin antibodies.  
Arrows: abnormal multinucleated erythrocytes. scale bar, 20 µm.  
(e) Representative photographs of Uba5 + / +  and Uba5 − / −  embryos at E11.5. 
The circulating erythrocyte volume is reduced in the yolk sac of Uba5 − / −  
embryos. scale bar, 2 mm. (f) Wright–Giemsa staining of peripheral blood 
cytospin cells prepared from the indicated genotypes at E11.5. scale bar, 
20 µm. (g) Percentage of abnormal erythrocytes shown in f. Bar graphs in c 
and g show the mean ± s.d. values of five mice from each group. statistical 
analysis was carried out using the unpaired t-test. *P < 0.05 (Welch test).
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Figure 2 | Uba5 is indispensable for the development of erythroid cells. 
(a) Representative FACs analysis. mouse fetal liver cells were freshly 
isolated from E11.5 embryos and labelled with a FITC-conjugated anti-CD71 
monoclonal antibody and PE-conjugated anti-Ter119 antibody. Left gate: 
proerythroblast population (Ter119med CD71high), right gate: basoerythroblast 
population (Ter119high CD71high). Axes mean log10 fluorescent intensity.  
(b) Quantification of erythroid colony-forming units (CFu-Es) and (c) 
erythroid burst-forming units (BFu-Es). Colony assays were carried out with 
cells prepared from fetal liver at E11.5. Uba5 deletion was associated with 
decreased erythroid progenitor activity. Data are means ± s.d. of five mice 
from each group. statistical analysis was performed using the unpaired  
t-test. *P < 0.05 (Welch test). (d) Representative FACs analysis. The myeloid 
progenitors (Lin − IL-7R − sca-1 − c-Kit + ) prepared from fetal liver cells of the 
indicated genotype mice at E11.5 were subfractionated into presumptive 
common myeloid progenitors (CD34highFcγRII/IIIlow), granulocyte/ 
macrophage progenitors (CD34highFcγRII/IIIhigh) and megakaryocyte/ 
erythroid progenitors (CD34lowFcγRII/IIIlow) by FACs. Axes mean log10 
fluorescent intensity. (e) TunEL staining of fetal livers of Uba5 + / −  and 
Uba5 − / −  mice at E12.5. scale bars: top panel, 100 µm; bottom panel, 20 µm. 
(f) Quantification of mRnA levels of erythroid-related genes, including  
Gata1, Fog1 and EPO, in Uba5-deficient liver at E11.5. Total RnAs were 
prepared from wild-type or Uba5-deficient livers and reverse transcribed into 
their respective cDnAs, which were used as templates for quantitative real-
time PCR. Values were expressed relative to the amount of the respective 
mRnA in the wild-type livers. The experiments were conducted three times. 
Data are means ± s.d. of three experiments. statistical analysis was carried 
out by the unpaired t-test. *P < 0.05 and **P < 0.01 (Welch test).ARTICLE
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(Supplementary Fig. S3c). In the Lin −  IL-7R − Sca-1 − c-Kit +  fraction, the 
CD34highFcγRII/IIIlow, CD34highFcγRII/IIIhigh and CD34lowFcγRII/IIIlow 
populations correspond to CMPs, GMPs and MEPs, respectively21.   
To determine whether Uba5 deficiency affects the differentiation steps 
of these progenitors upstream of BFU-Es and megakaryocytes, the 
above method was applied to analyse progenitors in Uba5-deficient 
embryos. As shown in Figure 2d, there was no decrease in the pro-
portion of CD34highFcγRII/IIIhigh (GMPs) populations among the dif-
ferent genotype livers (23.3 ± 2.1% versus 25.4 ± 4.8%, n = 3), and the 
proportion of CD34highFcγRII/IIIlow (CMPs) was increased in Uba5-
deficient fetal livers (46.0 ± 1.2% versus 59.6 ± 2.3%, n = 3, P < 0.05). In 
contrast, the proportion of CD34lowFcγRII/IIIlow population (MEPs) 
was lower in Uba5 − / −  fetal livers (17.1 ± 0.750% versus 4.1 ± 3.5%, 
n = 3, P < 0.05). These results suggest that Uba5 is indispensable for 
the development of MEPs, but not of GMPs, from CMPs.
Loss of Uba5 is accompanied by cell death. The total number of 
fetal liver cells in Uba5-deficient embryos was significantly lower 
than in wild-type embryos (Fig. 1c). This reduction implies massive 
loss of erythroid progenitors in Uba5-deficient fetal livers. Indeed, 
terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin 
nick-end labelling (TUNEL) staining showed a significant increase 
in apoptosis in Uba5-deficient fetal livers at E12.5 (Fig. 2e). Quanti-
tative real-time PCR analysis showed underexpression of genes that 
are specifically expressed in erythroid progenitors, such as Gata1, 
Fog1, β-globin and EpoR (erythropoietin receptor), in Uba5-defi-
cient fetal livers (Fig. 2f). The expression of Epo (erythropoietin) 
mRNA was augmented in mutant fetal livers, probably because of 
feedback regulation emanating from the inefficient erythropoiesis 
in Uba5 − / −  embryos (Fig. 2f). Taken together, these results suggest 
that, in addition to efficient differentiation of MEPs, Uba5 is essen-
tial for the survival of erythroid progenitors.
Generation of transgenic mouse lines of Uba5 driven by G1HRD. 
It is plausible that the defective erythropoiesis and megakaryopoie-
sis due to loss of Uba5 occurs in a cell-autonomous manner because 
no impairment of Epo expression was noted in mutant fetal livers 
(Fig. 2f). To prove this hypothesis, we generated transgenic (Tg) 
mice that expressed both Uba5 and GFP cDNAs under the control 
of the Gata1 gene haematopoietic regulatory domain (G1HRD)22  
(Supplementary Fig. S4a). GATA1 has an important role in erythro-
poiesis and megakaryopoiesis23,24. Expression of GATA1 driven by   
G1HRD rescues the mid-gestational embryonic lethality of Gata1   
knockdown mutant mice (Gata1.05) (ref. 25). Among several Tg 
lines,  Uba5#90  exhibited  the  highest  expression  of  Uba5  in  the 
spleen and bone marrow (Supplementary Fig. S4b). In addition, 
peripheral blood cells from Uba5#90 mice were positive for GFP,   
a  surrogate  marker  for  the  transgene  (Supplementary  Fig.  S4c).   
To further verify that the Uba5 transgene was driven by G1HRD,   
we examined the lineage of GFP-expressing cells. In Uba5#90 Tg 
mice, the majority of GFP-positive cells were found in erythroid (Sup-
plementary Fig. S4d) or megakaryocytic (Supplementary Fig. S4e)   
lineages. In contrast, GFP-positive cells were hardly detected in lym-
phoid (T cells: CD3 + , B cells: B220 + ; see Supplementary Fig. S4f) 
and myeloid (Gr1 + Mac1 + , see Supplementary Fig. S4g) lineages. 
These results indicate that the expression of Uba5 in the Uba5#90 
line reflects that of the endogenous Gata1 gene, implying that arti-
ficial Uba5 is produced in erythroid and megakaryocytic lineages. 
Therefore, we used the Uba5#90 line in this study.
Cell-autonomous impairment of erythropoiesis in Uba5 − / −  mice. 
Uba5 + / −  mice were crossed with G1HRD-Uba5 transgenic mice to 
generate mice that expressed Uba5 in the erythroid lineage (Uba5 − / − ; 
TgUba5, hereafter referred to as Uba5-rescue mice). All Uba5-rescue   
mouse  embryos  were  alive  at  E13.5,  in  contrast  to  the  death   
in utero of Uba5-deficient embryos at the same stage (Table 2), and 
were morphologically indistinguishable from control mice (Fig. 3a). 
However,  the  rescue  mouse  embryos  appeared  smaller  than  their 
control littermates at E15.5 and died by E18.5 (Fig. 3a and Table 2). 
Importantly, the hypoplasia observed in Uba5-deficient fetal livers (see   
Fig. 1a,b) was significantly ameliorated by the specific expression of 
Uba5 in the erythroid lineage (Fig. 3a,b and Supplementary Fig. S5a). 
The abnormal multinucleated erythrocytes that were detected in the 
fetal liver or peripheral blood of Uba5 − / −  embryos were not observed 
in the rescue embryos (Fig. 3b,d and Supplementary Fig. S5a).
Next, we examined the effect of Uba5 expression in the erythroid 
lineage on the differentiation of proerythroblasts and basophilic 
erythroblasts in Uba5 − / −  mice. The decreased population of pro-
erythroblasts and basophilic erythroblasts in Uba5-deficient fetal 
liver  (4.2 ± 3.2%  and  1.0 ± 0.6%,  respectively,  n = 3,  Fig.  2a)  was 
rescued by forced expression of Uba5 (9.7 ± 1.6% and 18.2 ± 8.7%, 
respectively, n = 3, Fig. 4a). Subsequently, we confirmed both CFU-
E and BFU-E activities in cells derived from Uba5-rescued mouse 
fetal livers (Fig. 4b,c, and compare with Fig. 2b,c) as well as the suffi-
cient ability to form CFU-Megs (Fig. 4d). As expected, the decreased 
population of MEPs in Uba5-deficient fetal liver (4.1 ± 3.5%, n = 3, 
Fig. 2d) was recovered in the rescued fetal liver (10.2 ± 1.6%, n = 3, 
Fig. 4e). Moreover, unlike the increase in TUNEL-positive cells in 
Uba5-deficient fetal livers, this phenomenon was hardly detected 
in the rescued mouse livers (Fig. 4f and Supplementary Fig. S5b). 
Taken together, these results indicate that Uba5 expression in eryth-
roid and megakaryocytic progenitors grants functional rescue of 
defective erythropoiesis and megakaryopoiesis in Uba5 − / −  mice.
Discussion
In this report, we demonstrated both the specificity of Uba5 for 
Ufm1 activation and the necessity of the enzyme in erythroid dif-
ferentiation, suggesting the essential role of one of the ubiquitin-
like modification systems, the Ufm1 system, in haematopoiesis and 
megakaryopoiesis.
Table 2 | Genotypes of embryos obtained from mating Uba5 + /– with Uba5 + /–;TgUba5 mice.
DNA source Genotype
Uba5 + / +  Uba5 + /– Uba5–/– G1HRD Uba5 Tg
Uba5 + / +  Uba5 + /– Uba5–/–
Alive Dead
Amnion (E13.5) 2 9 0 6 6 2 0
Amnion (E14.5) 2 3 0 3 4 1 0
Amnion (E15.5) 5 14 0 4 10 4 0
Amnion (E16.5) 5 6 0 3 4 0 0
Amnion (E17.5) 0 9 0 1 6 0 0
Amnion (E18.5) 3 9 0 3 4 0 3
Tails (P1) 31 40 0 19 29 0 —
Embryos were genotyped by PCR analysis.ARTICLE     
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The most characteristic feature of Uba5-deficient erythroblasts 
was the involvement of the multistep process of erythroid differen-
tiation. For instance, despite the insufficient differentiation of MEPs 
in mutant mice (Fig. 2d), partial retention of CFU-E and BFU-E 
activities was evident (Fig. 2b,c), implying that Uba5-deficient cells 
that overcome the differentiation step of MEPs can differentiate into 
mature cells. However, mutant erythroid cells eventually became 
multinucleated and exhibited an abnormal morphology (Fig. 1b,f). 
Such abnormalities throughout the multistage process were never 
observed in knockout mice for transcription factors and cytokine 
receptors that regulate erythroid differentiation, such as the GATA 
family and EPO-R23–26. The initiation of each step in erythroid dif-
ferentiation is controlled by the combination of expression of vari-
ous transcription factors and signal transducers activated by specific 
cytokines5,6. Thus, it is plausible that the Ufm1 system modulates 
the expression levels and/or activation of erythropoiesis-supporting 
transcription factors. Identification of Ufm1 target(s) is necessary 
to elucidate how protein modification by Ufm1 regulates eryth-
roid development. In addition, as the volume of circulating primi-
tive erythrocytes in the yolk sac was reduced (Fig. 1e) and because 
such primitive erythrocytes were multinucleated and also showed 
an abnormal morphology (Fig. 1d,f), it is apparent that impairment 
of both primitive and definitive erythropoiesis is the main cause of 
death in utero of Uba5-knockout mice before E13.5 (Table 1). How-
ever, in contrast to the almost complete blockade of definitive eryth-
roid differentiation in mutant embryos, the expression of ε-globin 
in the fetal liver was similar to that in control fetal liver (Fig. 2f), 
suggesting a relatively mild defect in primitive erythropoiesis. Thus, 
we assume that Uba5 deficiency has different effects on primitive 
and definitive erythropoiesis. Meanwhile, it is obvious that Uba5 
is indispensable for the later stage of development because Uba5-
rescued mice did not survive in spite of the marked improvement   
in Uba5-based defective erythropoiesis and megakaryopoiesis (Figs 3   
and 4). The cause of death might be because of the severe liver   
hypoplasia that was evident in rescued embryos compared with the 
control embryos (Fig. 3a).
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Figure 4 | Suppression of defective differentiation of both erythrocytes 
and megakaryocytes following expression of Uba5 in erythroid lineage. 
(a) FACs analysis. mouse fetal liver cells were freshly isolated from  
control and rescued mice at E11.5 and labelled with an FITC-conjugated 
anti-CD71 monoclonal antibody and PE-conjugated anti-Ter119 antibody. 
Left gate: proerythroblast population (Ter119med CD71high), right gate: 
basoerythroblast population (Ter119high CD71high). Axes mean log10 
fluorescent intensity. (b) Quantification of erythroid colony-forming units 
(CFu-Es) and (c) erythroid burst-forming units (BFu-Es). Colony assays 
were carried out with cells prepared from control and rescued fetal liver 
at E11.5. The number of CFu-E (b) and BFu-E (c) colonies remained 
unchanged in both genotypes. Data are means ± s.d. of five mice from 
each group. (d) Colony formation assay for megakaryocytes (CFu-meg). 
The assays were carried out with cells prepared from the fetal liver of 
the indicated genotypes at E11.5. Uba5 deletion was accompanied by 
a weaker megakaryocytic differentiation activity, and this defect was 
suppressed by forced expression of uba5 in megakaryocytic lineage. Data 
are means ± s.d. of Uba5 + / −  (n = 3), Uba5 − / −  (n = 4) and Uba5 − / − ;TgUba5 
(n = 3). statistical analysis was carried out using the unpaired t-test. 
**P < 0.01 (Welch test). (e) FACs analysis. The myeloid progenitors 
(Lin − IL-7R − sca-1 − c-Kit + ) prepared from liver cells of control and rescued 
fetuses at E11.5 were subfractionated into presumptive common myeloid 
progenitors (CD34highFcγRII/IIIlow), granulocyte/macrophage progenitors 
(CD34highFcγRII/IIIhigh) and megakaryocyte/erythroid progenitors  
(CD34lowFcγRII/IIIlow) by FACs. Axes mean log10 fluorescent intensity.  
(f) TunEL staining of the fetal livers of control and rescue mice at E12.5. 
scale bars: top panel, 100 µm; bottom panel, 20 µm.
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Figure 3 | Correction of anaemia in Uba5-deficient mice by expression 
of Uba5 in erythroid lineage. (a) Embryonic morphology of Uba5 rescue 
mice. Representative photographs of Uba5 + / + ;TgUba5 and Uba5 − / − ;TgUba5 
embryos at various embryonic stages. scale bar, 2 mm. (b) Haematoxylin 
and eosin-stained fetal liver sections of Uba5 + / + ;TgUba5 and Uba5 − / − ;TgUba5 
mice at E11.5. scale bars: left panel, 1 mm; right panel, 20 µm. (c) number 
of erythroid cells in fetal livers of Uba5 + / + ;TgUba5 and Uba5 − / − ;TgUba5 mice 
at E11.5. Data are means ± s.d. of five mice from each group. (d) Wright–
Giemsa-stained samples of peripheral blood cytospin cells prepared from 
control and rescued mice at E11.5. scale bar, 20 µm. (e) Percentage of 
abnormal erythrocytes shown in d. Data are means ± s.d. of five mice in 
each group.ARTICLE
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The field of haematopoiesis has witnessed tremendous progress 
in the past decade, specifically in delineating the interplay between 
lineage-specific cytokines and transcription factors and uncovering 
the kaleidoscopic pathways of erythrocyte biogenesis in mice5,6. The 
present results emphasized the importance of Uba5 in the devel-
opment  of  MEPs  from  CMPs.  They  also  demonstrated  that  the 
expression of Uba5 in the erythroid lineage is sufficient for rescuing 
Uba5 − / −  mouse embryos from severe anaemia. Although we cannot 
exclude other possible function(s) for Uba5 distinct from protein 
conjugation, as is known for Uba4, the E1 enzyme of the Urm1 sys-
tem3, the results highlight the critical role of the Ufm1 system in the 
cell-autonomous differentiation process of erythroid progenitors.
Methods
Generation of Uba5-knockout mice. The Uba5 gene was isolated from a mouse 
B6/C57BL BAC library (MHS1011-58540, Open Biosystems) by hybridization 
screening. The Uba5 targeting vector was constructed by inserting the neomycin 
resistance gene instead of the segment that encodes the conserved active-site 
cysteine residue (Cys250) necessary for activation of Ufm1 (Supplementary Fig. 
S2a). The targeting vector was electroporated into mouse TT2 ES cells, selected with 
G418 (250 µg ml − 1; Invitrogen), and then screened for homologous recombinants 
by Southern blot analysis. Southern blot analysis was performed by digesting 
genomic DNA with SpeI (TAKARA BIO) and hybridization to detect 7-kbp and 4-
kbp bands that correspond to the wild-type and mutant alleles, respectively. Geno-
typing of mice was performed by PCR using three primers: 543Fw 5′-CAACTTT 
GAAGCTCGAATGG-3′, Exon7Rv 5′-CATCCATGTCTGACCAAGTT-3′ and 
Neopr2 5′-GAAGGGACTGGCTGCTATTGGGCGAAGTGC-3′.
Generation of transgenic mice. Each Uba5- and GFP-cDNA was subcloned into 
the G1HRD vector25. The resultant constructs, G1HRD-Uba5 and G1HRD-GFP, 
were linearized, and the purified DNAs were co-microinjected into fertilized BDF1 
eggs according to standard procedures. Founders were screened by PCR using the 
following primer sets: for Uba5, the above-described 543Fw and 867Rv 5′-TCAT 
GAACATGGTAGGGAAA-3′, and for GFP, GFP-Fw 5′-AGCAAGGGCGAG 
GAGCTGTTCACC-3′ and GFP-Rv 5′-TGCCGTCGTCCTTGAAGAAGATG-3′. 
Uba5- and GFP-double positive mice were analysed. All experiments involving 
animals described in the present study were approved by the Animal Ethics Review 
Committee of the Tokyo Metropolitan Institute of Medical Science.
Cell culture and transfection. The media and reagents for cell culture were 
purchased from Life Technologies. HEK293T and MEFs were grown in DMEM 
containing 10% FCS, 5 U ml − 1 penicillin and 50 µg ml − 1 streptomycin. HEK293T 
cells at subconfluence were transfected with the indicated plasmids using Fugene 
6 reagent (Roche Molecular Biochemicals). Uba5 + / +  and Uba5 − / −  MEFs prepared 
from 10.5-day embryos were transfected with pMESVts vector, an SV40 large T-an-
tigen expression vector, to establish immortalized MEFs14. The immortalized cells 
were further transfected with the indicated plasmids using the Neon Transfection 
System (Invitrogen). Cells were analysed at 24 h after transfection.
Immunological analysis. For immunoblot analysis, cells were lysed with ice-cold 
TNE buffer (10-mM Tris-Cl, pH 7.5, 1% Nonidet P-40, 150-mM NaCl, 1-mM 
EDTA and protease inhibitors), and the lysates were separated by the NuPage 
system (Invitrogen) with 12% bis-tris gels and MOPS-SDS buffer and transferred 
to a polyvinylidene difluoride membrane. Mouse monoclonal anti-FLAG antibody 
(M2; Sigma Chemical), Anti-actin antibody (MAB1501R; Chemicon Internation-
al), Rabbit polyclonal anti-GFP antibody (A6455; Invitrogen), anti-Uba5 antibody12 
and anti-Ufm1 antibody12 were used for immunodetection. Development was 
carried out with the Western lighting detection kit (PerkinElmer). The primary an-
tibodies were diluted in the ratio 1:500 with 0.01-M Tris-buffered saline (150 mM 
NaCl) containing 0.025% Tween-20.
For immunoprecipitation analysis, cells were lysed using 200 µl of TNE, and 
the lysate was then centrifuged at 10,000×g for 10 min at 4 °C to remove debris. 
Further, 800 µl of TNE and 10 µl of Anti-FLAG M2 agarose affinity gel (Sigma 
Chemical) or Agarose-conjugated anti-GFP (MBL) were added to the lysate, and 
the mixture was mixed under constant rotation for 12 h at 4 °C. The immuno-
precipitates were washed five times with ice-cold TNE. The complex was boiled 
for 10 min in SDS sample buffer in the presence of β-mercaptoethanol to elute 
proteins and centrifuged at 10,000×g for 5 min. The supernatant was subjected to 
SDS–polyacrylamide gel electrophoresis, transferred to a polyvinylidene difluoride 
membrane and analysed by immunoblotting with Anti-GFP antibody (A6455; 
Invitrogen), anti-Ufm1 antibody12 or anti-Uba5 antibody12.
Histological examination. Embryos in utero were dissected at various stages of devel-
opment and then fixed in 4% Paraformaldehyde (Nacalai Tesque), paraffin-embedded  
and sectioned. Paraffin sections were stained with Meyer’s haematoxylin and 
eosin. Apoptotic cells were detected by TUNEL assay27. Briefly, cryosections were 
pretreated with 20 µg ml − 1 proteinase K at room temperature for 15 min and then 
incubated with 100-U ml − 1 TdT and 10-nmol ml − 1 biotinylated 16-2′-dUTP in TdT 
buffer (100-mM sodium cacodylatye, pH 7.0, 1-mM cobalt chloride, 50-µg ml − 1 
gelatin) at 37 °C for 60 min. They were further incubated with peroxidase-conjugated 
streptavidin for a conventional diaminobenzidine stain. Peripheral blood obtained 
from embryos was stained with Wright Stain Solution (Wako Pure Chemical Indus-
tries) and then with Giemsa Stain Solution (Wako Pure Chemical Industries).
Flow cytometry. Single cell suspensions were prepared from livers of embryos at 
E11.5. The cells were incubated in PBS containing 2% fetal bovine serum (FBS; 
Sigma Chemical) and 2.5-µg ml − 1 Fc-block (CD16/CD32, 2.4G2, BD Pharmingen) 
for 15 min on ice and then stained with antibodies for 20 min on ice. Antibodies for 
Biotin-CD4 (H129.19), CD8 (53-6.7), B220 (RA3-6B2), Gr-1 (RB6-8C5), Ter119 
(TER119), FITC (Fluorescein isothiocyanate)-CD71 (C2), PE (phycoerythrin)-
Ter119 (TER119), biotin-Sca-1 (E13-161.7), biotin-IL7R (B12-1), FITC-c-Kit 
(2B8), PE-FcγRII/III (2.4G2), PE-CD61 (2C9.G2), PE-B220 (RA-6B2), APC-CD3 
(17A2), PE-Gr1 (RB6-8C5) and APC-Mac1 (M1/70) were purchased from BD 
Pharmingen. Streptavidin-ECD (Beckman Coulter) was used as the secondary 
antibody for biotin. APC (allophycocyanin)-CD34 (RAM34) was purchased from 
e-Bioscience. The samples were analysed using a FACSCanto II Flow Cytometer 
(Becton Dickinson). The data were analysed with the Diva 5.0 program (Becton 
Dickinson). The experiments were conducted three times independently, and their 
reproducibility was confirmed.
Colony assays. For the CFU-E assay, 5,000 fetal liver cells were plated in 1 ml of 
Serum-free methylcellulose (M3234, Stem Cell Technology) supplemented with 
10% FBS (Sigma Chemical), 4 U ml − 1 Human erythropoietin (Chugai Pharmaceu-
tical) and IMDM. For the BFU-E assay, 5,000 fetal liver cells were plated in 1 ml 
of serum-free methylcellulose supplemented with 10% FBS (Sigma Chemical), 
4 U ml − 1 Human erythropoietin (Chugai Pharmaceutical), IMDM and 100-ng ml − 1 
rmSCF (Kyowa Hakko Kirin). For the CFU-Meg assay, fetal liver cells were cul-
tured with MegaCult-C Kit (Stem Cell Technology) in the presence of 5-ng ml − 1 
thrombopoietin. Colonies were maintained at 37 °C under humidification and 5% 
CO2. Colonies were scored on day 3 (CFU-E) and on day 7 (BFU-E) by staining 
with benzidine dihydrochloride. On day 8, clusters containing  > 10 megakaryo-
cytes were counted as CFU-Meg, on the basis of the manufacturer’s instructions.
Quantitative real-time PCR. Using a Transcriptor First Strand cDNA Synthesis 
Kit (Roche Applied Science), cDNA was synthesized from 1 µg of total RNA. 
Quantitative PCR was performed using LightCycler 480 Probes Master (Roche  
Applied Science) in a LightCycler 480 (Roche Applied Science). Signals were  
assessed relative to that of β-glucuronidase (GUS). The sequences of the primers used 
were Gata1 Fw, 5′-GAATCCTCTGCATCAACAAGC-3′; Gata1 Rv, 5′-GGGCAA 
GGGTTCTGAGGT-3′; Fog1Fw, 5′-AGGCCCCAGGATGAAGAG-3′; Fog1Rv,  
5′-ATCCTGCAGTGCCAGCTC-3′; ε-GlobinFw, 5′-GATGGAAAAAGATCC 
AAGCAA-3′; ε-GlobinRv, 5′-CACTGTAGCAAGCCGATTTTT-3′; β-GlobinFw, 
5′-GGAAAGGTGAACTCCGATGA-3′; β-GlobinRv, 5′-TGGGTCCAAGGGTAG 
ACAAC-3′; EpoFw, 5′-TCTGCGACAGTCGAGTTCTG-3′; EpoRv, 5′-CTT 
CTGCACAACCCATCGT-3′; EpoRFw, 5′-CCTCATCTCGTTGTTGCTGA-3′; 
EpoRRv, 5′-CAGGCCAGATCTTCTGCTG-3′; GusFw, 5′-CTCTGGTGGCCTT 
ACCTGA-3′; and GusRv, 5′-CTCAGTTGTTGTCACCTTCACC-3′.
Reverse transcription–PCR analysis. cDNA was synthesized from 5 µg of DNase 
I-treated total RNA using the SuperScript First-Strand Synthesis System (Invitro-
gen) and oligo (dT )12–18 primers. The specific primers were 5′-GTGGATTAGAAG 
AAGGACAAC-3′ and 5′- TCATGAACATGGTAGGGAAA-3′ for Uba5, and 
5′-GAGCTGAACGGGAAGCTCAC-3′ and 5′-ACCACCCTGTTGCTGTAGC-3′ 
for GAPDH.
Statistical analysis. Statistical analysis was carried out using the unpaired t-test 
(Welch test) equipped with Excel 2008. Values are means ± s.d. For all graphs, data 
are presented as means ± s.d. A P-value  < 0.05 denoted statistical significance. 
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